 |
|
|
| |
LEDIPASVIR/SOFOSBUVIR+/-RIBAVIRIN IN HCV POST-TRANSPLANT PATIENTS: REAL-WORLD HETEROGENEOUS POPULATION FROM THE TRIO NETWORK
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Bsrcelona
Steven Flamm* 1, Bruce Bacon2, Michael Curry3, Douglas Dieterich4, Lauren Guest5, Kris Kowdley6, Yoori Lee5, Naoky Tsai7, Zobair Younossi8, Nezam Afdhal3
1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Saint Louis University School of Medicine, Saint Louis, MO, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Icahn School of Medicine at Mount Sinai, New York, NY, 5Trio Health Analytics, La Jolla, CA, 6Liver Care Network, Swedish Medical Center, Seattle, WA, 7Queens Medical Center, University of Hawaii, Honolulu, HI, 8Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, United States
|
| |
|
|
|
|
|
